Editorials

Experts, patients, and advocates gathered in Barcelona for the 2nd Cushing’s Syndrome Awareness Day Conference—an event that not only deepened understanding of the lasting neurocognitive and emotional burden of the disease but also marked a major milestone: the launch of Spain’s first national Cushing’s patient association (ANPC). Discover how this meeting is shaping a more holistic, patient-centred future for Cushing’s care.

Neoplastic hypercortisolism – whether pituitary, adrenal, or ectopic – remains one of the most challenging arenas in endocrine oncology. The Editorial Board takes the opportunity to highlight key publications in medical therapy from 2025.

As the year draws to a close, the Editorial Board takes the opportunity to highlight key publications on post-adrenalectomy outcomes relating to MACS.

Mild autonomous cortisol secretion (MACS) has recently emerged as one of the most debated areas in Cushing’s diagnostics. Read on to find out more from one of the leading clinical researchers in the field.

The two forms of adrenocortical nodular disease (PPNAD and BMAD) have different aetiologies that demand distinct treatment approaches – understanding their respective cause can also lead to a personalized approach to care. Read on to discover more.

Read on to see what the Editorial Board says about Cushing’s syndrome in different age groups, particularly the recent study that shows differences in presentation between younger patients and those aged 65 years or above.